Search

everythinglearnresearchcommunity

for

Search:↓

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

The conclusion is that proper evaluation and treatment of hair loss in midlife women is important, considering the emotional impact and potential for various treatments.

Androgens play a key role in hair growth and disorders like baldness and excessive hairiness.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

Many males in Jordan misuse oral contraceptive pills for hair growth, muscle gain, and acne treatment.

Hormone therapy is safe and effective for transgender adults, but requires regular monitoring and mental health support.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Steroidogenic isoenzymes may help improve treatments for common hair loss.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Anagen grow may effectively treat hair loss by blocking testosterone and reducing enzyme activity.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Transgender patients need proper skin care, especially when undergoing hormone treatments, to manage issues like acne and hair loss.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

A male with aromatase deficiency improved bone health with estradiol treatment.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

The contraceptive implant Implanon may be linked to hair loss, but the reported case of alopecia could be unrelated to the implant.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Formestane is a preferred second-line treatment for advanced breast cancer in postmenopausal women because it's effective and has fewer side effects.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

SHBG may be a useful early indicator and treatment target for PCOS.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

The document concludes that diagnosing PCOS in teenagers is difficult and should focus on specific hormone levels and menstrual irregularities, while also considering treatment for symptoms and related health issues.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.